Nike facing supply chain issues, Alzheimers drug drops in price

Name: Nike facing supply chain issues, Alzheimers drug drops in price
Uploaded: 2021-12-21T20:01:14Z
Duration: 1 min 28 s
Description: Biogen slashes Aduhelm prices, the first new treatment of Alzheimers, due to concerns over safety, effectiveness and an initially large price tag. COVID-19 mandates in China are negatively impacting Nike's factory operations.

Biogen slashes Aduhelm prices, the first new treatment of Alzheimers, due to concerns over safety, effectiveness and an initially large price tag. COVID-19 mandates in China are negatively impacting Nike's factory operations.

Posted December 21, 2021 2:01pm CST